development of monoclonal antibodies to the CD3 zeta chain, known as âclone TCR-48″
Latest
Yissum’s Summer 2025 Newsletter showcases new technologies, strategic partnerships, and the launch of the Innovation Lab for National Challenges. Discover how we’re advancing innovation with real-world impact.